Rimadyl vet. (12.5 - 25 kg)
Active substance
ATC code
Species
Dogs.
Indications
For analgesia and reduction of chronic inflammation, for example in degenerative joint disease in the dog.
The tablets can also be used in the management of post-operative pain.
Dose to be administered and administration route
For oral administration. The tablets are palatable and willingly consumed by most dogs when offered.
An initial dose of 2 to 4 mg carprofen per kg bodyweight per day is recommended to be given as a single dose or in two equally divided doses.
Subject to clinical response, the dose may be reduced after 7 days to 2 mg carprofen/kg bodyweight/day given as a single dose.
To extend analgesic and anti-inflammatory cover post-operatively, parenteral therapy with Rimadyl Small Animal Injection may be followed with the tablets at 4mg/kg/day for up to 5 days.
Duration of treatment will be dependent upon the response seen. Long term treatment should be under regular veterinary supervision.
Adverse reactions
Typical undesirable effects associated with NSAIDs, such as vomiting, soft faeces/diarrhoea, faecal occult blood, loss of appetite and lethargy have been reported. These adverse reactions generally occur within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal. If adverse reactions occur, use of the product should be stopped and the advice of a veterinarian should be sought. As with other NSAIDs there is a risk of rare renal or idiosyncratic hepatic adverse events.
Similar products
Showing 4 of 4 results
Rimadyl vet. (12.5 - 25 kg)
Rimadyl vet. (12.5 - 25 kg)
Rimadyl vet. (12.5 - 25 kg)
